Ausgabe 2/2008
Inhalt (18 Artikel)
Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B
Teerha Piratvisuth
Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure
Stephen Locarnini
Hepatitis B reactivation after chemotherapy: two decades of clinical research
George K. K. Lau
Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues
Nancy Leung
Should chronic HBV infected patients with normal ALT treated: debate
Shiv Kumar Sarin, Manoj Kumar
Chronic HBV infection with persistently normal ALT b. not to treat
Kwang-Hyub Han, Do Young Kim
Nonalcoholic fatty liver disease in a district general hospital: clinical presentation and risk factors
Wing-Kin Syn, Peter Nightingale, Jeffrey M. Bateman
A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)
Yin-Mei Lee, Dede S. Sutedja, Chun-Tao Wai, Yock-Young Dan, Myat-Oo Aung, Lei Zhou, Chee-Leong Cheng, Aileen Wee, Seng-Gee Lim
Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease
Payal Bhardwaj, Kaushal Madan, Sandeep Thareja, Yogendra Kumar Joshi, Anoop Saraya
Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary report
S. Rajindrajith, A. S. Dassanayake, J. Hewavisenthi, H. J. de Silva
Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis
Norimasa Miura, Hiroko Kabashima, Mika Shimizu, Reina Sato, Tomoe Tsukamoto, Tomomi Harada, Shunsaku Takahashi, Ryujin Endo, Nobuaki Nakayama, Yasuhiro Takikawa, Satoshi Mochida, Kazuyuki Suzuki, Junichi Hasegawa, Goshi Shiota
Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers
Minoru Nakamura, Kenji Funami, Atsumasa Komori, Terufumi Yokoyama, Yoshihiro Aiba, Aiko Araki, Yasushi Takii, Masahiro Ito, Mutsumi Matsuyama, Makiko Koyabu, Kiyoshi Migita, Ken Taniguchi, Hikaru Fujioka, Hiroshi Yatsuhashi, Misako Matsumoto, Hiromi Ishibashi, Tsukasa Seya
Economic evaluation of a surveillance program of hepatocellular carcinoma (HCC) in India
Shashi Bala Paul, Vishnubhatla Sreenivas, Manpreet Singh Gulati, Kaushal Madan, Arun Kumar Gupta, Sima Mukhopadhyay, Subrat Kumar Acharya
Prognostic analysis of pulmonary metastases from hepatocellular carcinoma
Shu-Min Zhang, Zhao-Chong Zeng, Zhao-You Tang, Jing Sun, Jie-Min Cheng, Rong Liu, Ping Wang, Bo-Heng Zhang
Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV)
Hie-Won Hann, Hee Bok Chae, Stephen R. Dunn
Metabolic profiles in patients with chronic hepatitis C: a case–control study
Ching-Sheng Hsu, Chun-Jen Liu, Chen-Hua Liu, Chi-Ling Chen, Ming-Yang Lai, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Spontaneous rupture of metastatic α-fetoprotein-producing gastric cancer of the liver
Tetsuro Sohda, Takayuki Hanano, Hisanori Miyamoto, Yoko Kitano, Kaoru Iwata, Masanori Yokoyama, Makoto Irie, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka